Why carry out this study?

Even though atopic dermatitis is highly prevalent in children and patients typically present with mild-to-moderate symptoms, the disease burden is not well established.

This study compared the clinical and economic burden for pediatric mild-to-moderate patients with atopic dermatitis.

What was learned from the study?

Total direct medical costs for pediatric patients with mild-to-moderate atopic dermatitis in Sweden are €118.9 million higher, cumulatively after 5 years, than in individuals without the disease.

Pediatric mild-to-moderate patients incur substantial clinical and economic burden in secondary care.